Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Lipocine testosterone drug Tlando fails for the thrid time to get USFDA approval

      Lipocine testosterone drug Tlando fails for the thrid time to get USFDA approval

      Medical Dialogues Bureau12 Nov 2019 9:15 AM IST
      The decision marks the third regulatory setback in over three years for Lipocine's Tlando, which aims to restore normal testosterone levels in men...
      Merck, Pfizer announce topline results of Phase III JAVELIN Gastric 100 trial evaluating Avelumab

      Merck, Pfizer announce topline results of Phase III JAVELIN Gastric 100 trial evaluating Avelumab

      Medical Dialogues Bureau12 Nov 2019 9:00 AM IST
      New Delhi: EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. recently announced...
      USFDA nod to Reblozyl, Celgenes rare blood disorder drug

      USFDA nod to Reblozyl, Celgene's rare blood disorder drug

      Medical Dialogues Bureau11 Nov 2019 1:13 PM IST
      The U.S. Food and Drug Administration said on Friday it had approved treatment for a rare blood disorder from Celgene Corp, which is in the process of...
      Wockhardt Q2 net loss widens to Rs 94 cr

      Wockhardt Q2 net loss widens to Rs 94 cr

      Medical Dialogues Bureau11 Nov 2019 1:11 PM IST
      New Delhi: Pharma major Wockhardt on Thursday reported widening of consolidated net loss to Rs 94.24 crore for the September quarter. The company had...
      Glenmark recalls over 2 lakh cartons of product in US

      Glenmark recalls over 2 lakh cartons of product in US

      Medical Dialogues Bureau11 Nov 2019 1:11 PM IST
      NEW DELHI: Drug maker Glenmark Pharmaceuticals is recalling close to 2.17 lakh cartons of Estradiol Vaginal inserts in the US market due to faulty...
      RedHill Biopharma Talicia wins USFDA nod for treating bacterial infection

      RedHill Biopharma Talicia wins USFDA nod for treating bacterial infection

      Medical Dialogues Bureau11 Nov 2019 9:15 AM IST
      The drug, Talicia, is an oral capsule comprising two antibiotics, amoxicillin and rifabutin, as well as omeprazole, a common treatment for...
      Delhi Pharmaceutical Sciences and Research University collaborates with China Pharma University for free research

      Delhi Pharmaceutical Sciences and Research University collaborates with China Pharma University for free research

      Medical Dialogues Bureau10 Nov 2019 4:52 PM IST
      This MoU will enable free research collaboration with China Pharmaceutical University(CPU). It is also planned to have some unique postgraduate level...
      Aurobindo Pharma USA recalls heartburn drug Ranitidine over cancer causing impurities

      Aurobindo Pharma USA recalls heartburn drug Ranitidine over cancer causing impurities

      Medical Dialogues Bureau10 Nov 2019 9:45 AM IST
      Aurobindo Pharma is second city-based drug company that has initiated the voluntary recall after the FDA announced an investigation into the reported...
      Sun Pharma reports net profit of Rs 1064 crore in Q2

      Sun Pharma reports net profit of Rs 1064 crore in Q2

      Medical Dialogues Bureau10 Nov 2019 9:30 AM IST
      Total revenue from operations during the period under review stood at Rs 8,123.35 crore as against Rs 6,937.63 crore in the year-ago quarter, said Sun...
      Abbott discovers new strain of HIV, keeping global health community step ahead of virus

      Abbott discovers new strain of HIV, keeping global health community step ahead of virus

      Medical Dialogues Bureau10 Nov 2019 9:00 AM IST
      New Delhi: Abbott announced recently that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1...
      Biogen to commercialize Samsung Bioepis 2 new ophthalmology biosimilars Lucentis, Eylea in major markets worldwide

      Biogen to commercialize Samsung Bioepis 2 new ophthalmology biosimilars Lucentis, Eylea in major markets worldwide

      Medical Dialogues Bureau10 Nov 2019 8:59 AM IST
      Under the terms of the proposed transaction, Biogen will make a $100 million upfront payment to Samsung Bioepis. Additionally, Biogen may pay Samsung...
      Weak financial health: IRDAI barrs Anil Ambani Reliance Health Insurance from selling policies

      Weak financial health: IRDAI barrs Anil Ambani Reliance Health Insurance from selling policies

      Medical Dialogues Bureau9 Nov 2019 12:10 PM IST
      In a release, the IRDAI said it was closely monitoring the situation and has assured Reliance Health Insurance Ltd (RHICL) policyholders that their...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok